Navidea to Report Manocept™ Results in Kaposi’s Sarcoma at the International Workshop on KSHV and Related Agents Jun 4, 2015
Navidea Reports First Quarter 2015 Financial Results; Reiterates 2015 Lymphoseek® Revenue Guidance May 12, 2015
Navidea Secures $60 Million Loan with CRG; Funding to Support Lymphoseek® Commercialization and Advancement of Development Pipeline May 11, 2015
Navidea Divests NAV5001, a Non-Core, Development-Stage Imaging Agent for Parkinson's Disease Apr 27, 2015
Navidea Data for Manocept™ CD206 Targeting Platform Demonstrate Potential to Impact Tumor-Associated Macrophages and Kaposi’s Sarcoma Tumor Cells Apr 22, 2015
Macrophage Therapeutics Announces Manocept™ Results in Kaposi’s Sarcoma Studies to Be Presented at the American Association of Cancer Research (AACR) Apr 15, 2015
Navidea Biopharmaceuticals Announces Presentation of Lymphoseek® Data at Society of Surgical Oncology Meeting Mar 25, 2015
